Compare, Analyse AJANTA PHARMA with ADCOCK INGRAM HOLDINGS LTD. - S. Africa - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AJANTA PHARMA vs ADCOCK INGRAM (S. Africa) - Comparison Results

ADCOCK INGRAM (S. Africa)
   Change

Adcock Ingram is a leading South African pharmaceutical manufacturer, marketer and distributor. The company occupies 10% share of the private pharmaceutical market in South Africa with a strong presence in over-the-counter (OTC) brands. Adcock is als... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 AJANTA PHARMA   ADCOCK INGRAM
EQUITY SHARE DATA
    AJANTA PHARMA
Mar-19
ADCOCK INGRAM
Jun-14
AJANTA PHARMA/
ADCOCK INGRAM
5-Yr Chart
Click to enlarge
High Rs1,422383-   
Low Rs898276-   
Sales per share (Unadj.) Rs233.5113.9-  
Earnings per share (Unadj.) Rs44.0-28.7-  
Cash flow per share (Unadj.) Rs52.2-23.8-  
Dividends per share (Unadj.) Rs9.000-  
Dividend yield (eoy) %0.80-  
Book value per share (Unadj.) Rs255.189.4-  
Shares outstanding (eoy) m88.02168.78-   
Bonus/Rights/Conversions BB--  
Price / Sales ratio x5.02.9 171.7%   
Avg P/E ratio x26.4-11.5 -229.7%  
P/CF ratio (eoy) x22.2-13.9 -160.5%  
Price / Book Value ratio x4.53.7 123.3%  
Dividend payout %20.50-   
Avg Mkt Cap Rs m102,08155,608 183.6%   
No. of employees `0006.84.3 158.4%   
Total wages/salary Rs m4,3073,490 123.4%   
Avg. sales/employee Rs Th3,022.64,476.9 67.5%   
Avg. wages/employee Rs Th633.4813.0 77.9%   
Avg. net profit/employee Rs Th569.1-1,128.1 -50.4%   
INCOME DATA
Net Sales Rs m20,55419,219 106.9%  
Other income Rs m211135 156.6%   
Total revenues Rs m20,76519,354 107.3%   
Gross profit Rs m5,664-3,331 -170.1%  
Depreciation Rs m721829 86.9%   
Interest Rs m12521 2.2%   
Profit before tax Rs m5,143-4,546 -113.1%   
Minority Interest Rs m0-13 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,273284 448.1%   
Profit after tax Rs m3,870-4,843 -79.9%  
Gross profit margin %27.6-17.3 -159.0%  
Effective tax rate %24.8-6.2 -396.1%   
Net profit margin %18.8-25.2 -74.7%  
BALANCE SHEET DATA
Current assets Rs m11,81214,076 83.9%   
Current liabilities Rs m3,7767,920 47.7%   
Net working cap to sales %39.132.0 122.1%  
Current ratio x3.11.8 176.0%  
Inventory Days Days77111 69.8%  
Debtors Days Days82124 65.8%  
Net fixed assets Rs m14,3988,205 175.5%   
Share capital Rs m17589 196.6%   
"Free" reserves Rs m22,2770-   
Net worth Rs m22,45215,085 148.8%   
Long term debt Rs m75,301 0.1%   
Total assets Rs m26,96228,497 94.6%  
Interest coverage x444.3-7.7 -5,746.5%   
Debt to equity ratio x00.4 0.1%  
Sales to assets ratio x0.80.7 113.0%   
Return on assets %14.4-15.2 -94.9%  
Return on equity %17.2-32.1 -53.7%  
Return on capital %23.0-19.8 -115.9%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m8,5800-   
CASH FLOW
From Operations Rs m3,7481,640 228.5%  
From Investments Rs m-2,228-504 442.3%  
From Financial Activity Rs m-1,4754,811 -30.6%  
Net Cashflow Rs m455,948 0.8%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ADCOCK INGRAM (S. Africa) is South Africa Rand. All data has been converted at 5.28 Rs / ZAR

Compare AJANTA PHARMA With: ACTAVIS (US)  MYLAN (US)  TEVA PHARMA (Israel)  

Compare AJANTA PHARMA With: WOCKHARDT  SHASUN PHARMA  NEULAND LABS  TORRENT PHARMA  ALEMBIC  



Today's Market

Sensex Ends Flat; Wipro & Hindalco Industries Among Top Nifty Gainers(Closing)

Indian share markets witnessed volatile trading activity throughout the day today and ended on a flat note.

Related Views On News

AJANTA PHARMA Announces Quarterly Results (3QFY21); Net Profit Up 64.2% (Quarterly Result Update)

Feb 5, 2021 | Updated on Feb 5, 2021

For the quarter ended December 2020, AJANTA PHARMA has posted a net profit of Rs 2 bn (up 64.2% YoY). Sales on the other hand came in at Rs 7 bn (up 15.0% YoY). Read on for a complete analysis of AJANTA PHARMA's quarterly results.

AJANTA PHARMA Announces Quarterly Results (2QFY21); Net Profit Up 46.3% (Quarterly Result Update)

Nov 6, 2020 | Updated on Nov 6, 2020

For the quarter ended September 2020, AJANTA PHARMA has posted a net profit of Rs 2 bn (up 46.3% YoY). Sales on the other hand came in at Rs 7 bn (up 11.4% YoY). Read on for a complete analysis of AJANTA PHARMA's quarterly results.

AJANTA PHARMA 2018-19 Annual Report Analysis (Annual Result Update)

Jun 24, 2019 | Updated on Jun 24, 2019

Here's an analysis of the annual report of AJANTA PHARMA for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of AJANTA PHARMA. Also includes updates on the valuation of AJANTA PHARMA.

More Views on News

Most Popular

India: Recovery Stalled by Vaccine Games? (The Honest Truth)

Apr 13, 2021

Ajit Dayal on how India's vaccine strategy will impact the markets.

4 Stocks to Make Your Portfolio Immune to the Second Covid Wave (Profit Hunter)

Apr 6, 2021

Rather than predicting the market, successful investing is more about preparing well and placing your bets accordingly.

An India Revival Stock I'm Bullish On... (Profit Hunter)

Apr 9, 2021

This could take India to the position of 3rd largest economy.

Why Did the Market Crash on Monday? (Fast Profits Daily)

Apr 13, 2021

In this video, I'll you what I think is the real reason behind yesterday's market crash.

Why the Market Fell Yesterday (Fast Profits Daily)

Apr 6, 2021

In this video, I'll tell you the two reasons why the market fell on Monday and how you can prepare yourself for such events in the future.

More
-->

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

OUR TOP 5 IDEAS

Free Report: Multibagger Stock Ideas 2021
Are You Making One of These 15 Costly Mistakes While Investing. Learn more!
Covid-19 Proof Multibagger Stocks - Download this FREE Report Now
Free Report: The Secret to Increasing Your Trading Profits Daily!
No Guessing, No Hunches, and No Missed Trends Ever! Join Us on YouTube Now.

AJANTA PHARMA SHARE PRICE


Apr 16, 2021 (Close)

TRACK AJANTA PHARMA

  • Track your investment in AJANTA PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON AJANTA PHARMA

AJANTA PHARMA 8-QTR ANALYSIS

COMPARE AJANTA PHARMA WITH

FEATURED VIDEOS

Market Crash: Picture Abhi Baaki Hai?

It's a Great Time to Buy Gold

The Dilemma of Investing in Bharti Airtel

Nifty: Bear Trap?

More Featured Videos

MARKET STATS